Spelling suggestions: "subject:"amedical care"" "subject:"asmedical care""
921 |
Total and segmented direct cost-of-care for stage IV non-small cell lung cancer in a privately insured populationBell, Allison Miriam 12 July 2011 (has links)
Introduction: New treatments for stage IV (adv) NSCLC have emerged this past decade. Recent pharmacoeconomic research has focused on cost of treatment, comparative costs of therapies, and cost/cost effectiveness of adding a biologic to traditional therapy. Drug cost is thought to be a primary driver of cost change in NSCLC, yet to our knowledge, characterization of the direct cost of NSCLC has not been published since the new treatments have emerged in the guidelines. Our primary objective was to characterize the direct and segmented cost of adv NSCLC from 2000-9. We also want to determine cost impact of new therapies, and cost trend from 2000-9. Methods: This PharMetrics claims database study includes diagnosed NSCLC patients [greater than or equal to] 20 yo. Small cell lung cancer was excluded. Claims were divided into disease segments and time periods representative of changes in therapy ("pre" (2000-2), "transition" (2003-5), and "current" (2006-9) periods). Descriptive statistics (median, interquartile range (IQR)), chi-square test (nominal data), and Wilcoxan rank sum tests were performed on the data. To adjust for baseline confounders, multivariate least squares regression models were created. Results: Costs are reported as medians in terms of per patient per month (pppm). Overall monthly cost (n=969) was $10,281 pppm. Diagnosis cost $6,601 pppm, active treatment cost $9,287 pppm, and end-of life cost $12,215 pppm. There was no difference in cost between the “transition” (n=439) and “current” (n=503) periods overall or for any segment of disease. Comorbidities had no effect on cost. For patients receiving at least 5 months of active treatment medication (n=316) total median cost was $144,147 per patient ($9,371 pppm). Discussion: There was no difference in cost between the transition and current periods, in regards to either overall cost or segmented cost. The most expensive segment was end-of-life, with a median cost exceeding $12,000 pppm. Surprisingly, comorbidities had no effect on cost. Newer agents (biologics, TKIs, and pemetrexed) represent only a modest portion of cost, with a majority of cost for stage IV NSCLC comprised of non-drug costs. / text
|
922 |
An analysis of the planning system of the Medical and Health Department / Hospital Services DepartmentLuk, Che-chung., 陸志聰. January 1993 (has links)
published_or_final_version / Public Administration / Master / Master of Public Administration
|
923 |
Clinical outcomes for patients with traumatic brain injury in Kowloon HospitalTang, Yuen-ming, Lewis., 鄧遠明. January 2001 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
924 |
Nurses' attitudes towards computerizationChiu, Y. M., 招以文. January 2004 (has links)
published_or_final_version / Nursing Studies / Master / Master of Nursing in Advanced Practice
|
925 |
Characteristics of non-attendance for re-enrollment in elderly health centres in Hong Kong: the role of socio-economic factors and self-perceived health曾守衡, Tsang, Sau-hang, Caroline. January 2002 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
926 |
An analysis of severe acute respiratory syndrome (SARS) and the management of Hong Kong's healthcare systemWu, Ka-yin, Christina., 鄔家燕. January 2004 (has links)
published_or_final_version / Public Administration / Master / Master of Public Administration
|
927 |
Cross-cultural validation and norming of the MOS 36-item short-form health survey (SF-36) on Chinese adults in Hong KongLam, Lo-kuen, Cindy., 林露娟. January 2003 (has links)
published_or_final_version / Medicine / Master / Doctor of Medicine
|
928 |
Planning models for hospital service allocationChu, Lisa., 朱麗莎. January 2000 (has links)
published_or_final_version / Mathematics / Master / Master of Philosophy
|
929 |
Doctor-Shopping: implications for continuity of care in Hong KongLo, Yen, Andrea., 盧茵. January 1995 (has links)
published_or_final_version / Community Medicine / Doctoral / Doctor of Philosophy
|
930 |
MEDICAL DECISION-MAKING AMONG LOWER-CLASS ANGLOS OF DOUGLAS, ARIZONABauwens, Eleanor January 1974 (has links)
No description available.
|
Page generated in 0.3846 seconds